TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Frequency of serological response to influenza vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent of Words Correctly Recognized in Noisy Conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Words Correctly Recognized in Quiet Conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale (VAS) Rating of SEDA NR
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hamstring flexibility angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSG-induced satiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency between P1 and Nova system for electrolyte parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between P1 and Nova for electrolyte parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bias at clinical decision levels between P1 and Nova
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outlier Detection in electrolyte Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Myotonia Behavior Scale (MBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of highest serum creatinine value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Alive
Endpoint domain: Mortality/survival
Primary endpoint: Readmitted to ICCU
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sensitivity and specificity of cfDNA methylation-based model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appendicular muscle mass index (AMMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAI SCORE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin 1B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TNF-ALPHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cardiorespiratory Fitness (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chloride Transport Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bicarbonate Transport Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway Surface Liquid pH Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mucous Viscosity Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial Killing Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in extended blood panel (EBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adipocytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inter-observer agreement of response assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal pain numerical scaling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 14-day CGM-derived Time in Range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Index Hospital Survival
Endpoint domain: Mortality/survival
Primary endpoint: Time to Mechanical Ventilator Liberation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Degree of pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Liver Frailty Index value at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline 6 Minute Walking Test value at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Maternal hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change of tCO2 during THRIVE ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of SpO2 during THRIVE ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Dementia Rating
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decrement on repetitive nerve stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Timed up-and go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limits of stability on NeuroCom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Handgrip strength on dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived functional fitness and health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: N-acylphosphatidylethanolamines (NAPEs) levels in biofluids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-acylethanolamines (NAEs) levels in biofluids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endocannabinoids levels in biofluids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterine blood vessel flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Adverse Drug Reaction (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Complete remission rate (CR rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early Clinical Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants reporting solicited administration site adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting solicited systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate (IR) of the first occurrence of a urine culture confirmed UTI due to E. coli
Endpoint domain: Adverse events/effects
Primary endpoint: PCOS Morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Percentage of Time in Range of Blood Glucose Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Donor cell implantation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real World Overall Survival (rwOS)
Endpoint domain: Mortality/survival
Primary endpoint: Anogenital distance (AGD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Cases Achieving Hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eosinophil count in esophageal tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: % of patients meeting daily mobility goal
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: % of patients with mobility measurements documented daily
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: % of patients receiving physical and/or occupational therapy consults
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: occurrence and times of nausea vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic Reasoning Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological Function Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurological Exam using Medical Research Council (MRC Scale) Scale for Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: North Star Ambulatory Assessment (NSAA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under Curve for serum insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area under Curve for Glucose Infusion Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ΔP values calculated with end-inspiratory airway pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MP values calculated with end-inspiratory airway pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants with local, regional and distant recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Level of finding meaning in life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: One-time puncture success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triglyceride glucose index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Itching level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in mean power output during a 30min cycling time trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in capillarization of the musculus vastus lateralis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in REM sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Spherical equivalent refraction power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dissection speed of the ESD procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Concordance correlation coefficient in small bowel exploration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowest oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative Pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autograft dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft Maturation Assessed by Signal-to-Noise Quotient (SNQ) on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft-Bone Integration Assessed by Signal Intensity (SI) on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Tunnel Volume Assessed by CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Primary Care Follow Up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prolongation of intravaginal ejaculatory latency time (IELT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in patient-reported outcomes using the Index of Premature Ejaculation (IPE) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in patient-reported outcomes using the Premature Ejaculation Diagnostic Tool (PEDT) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in pressure-flow metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants Screened as Eligible
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Screened Participants That Enroll
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Enrolled Participants That Are Retained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants Who Perceive a Benefit From the Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of Critical Tasks Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Data Completeness on Clinical Outcomes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Two-year Recurrence Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants who discontinue study intervention due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Level of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Monitoring of renal oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Dementia conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with a dose change
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with interruption or permanent discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with Upadacitinib drug compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in Tear Break Up Times (TBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Device-related Ocular Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Tongue peak pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Meniscal extrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of patients recruited per month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients who completed the protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postprandial blood TEAA profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Subjects with Acute Device-Related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Alive after 2 Years
Endpoint domain: Mortality/survival
Primary endpoint: Leicester Cough Questionnaire (LCQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Duration From Treatment Initiation to Onset of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of Adverse Events From Onset to Resolution
Endpoint domain: Adverse events/effects
Primary endpoint: Eye movement gaze fixations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-treatment Negative Affectivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: progression-free survival (rwPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with biopsy proven rejection and/or acute allograft dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline Maximal Mouth Opening on Postoperative Follow Up Visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain Intensity-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproductive Concerns After Cancer Scale
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Patient Satisfaction Evaluation Form Based on Watson's Processes of Healing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportion of complete remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Dose Limited Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment associated adverse events (AE) and serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment associated changes in clinically significant laboratory safety test values
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants that Successfully Receive TBio-4101
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echocardiography (ECHO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Letters amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amino acid uptake into tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cystolic protein in tumor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Bruininks-Oseretsky Test of Motor Proficiency (BOT-2) for Hand Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality Upper Extremity Skills Test (QUEST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lafayette Manual Muscle Tester
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBsAg seroclearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Depression symptoms measured by PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety symptoms measured by GAD-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adjustment difficulties measured by BASE-6
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Alcohol use symptoms measured by USAUDIT
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Drug use symptoms measured by DAST-10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Secondary vertebral fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline Beck Depression Inventory (BDI)-II scores at 10 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline State Trait Anxiety Inventory (STAI) scores at 10 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline Perceived Stress Scale (PSS)-10 scores at 10 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brief Pain Inventory-Interference (BPI-INT)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Veterans RAND 36-Item Health Survey (VR-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PEG-3
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total post operative analgesic consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety and tolerability of TRX-100
Endpoint domain: Adverse events/effects
Primary endpoint: Number of active smokers at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale values
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Boston carpal tunnel questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Heart rate peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood bilirubin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Regional sweating rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the percentage of naïve B cells out of total B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the plasma concentration curve from zero to infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of AU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of AU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Traumatic Grief Inventory-Kids-Self report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preoperative deformity angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative deformity angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of molar intrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast Enhancement Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total Daily Milk Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resection limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid Use (Number of Doses)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Passage of olfactory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term mortality rates
Endpoint domain: Mortality/survival
Primary endpoint: Change in prostate-specific antigen (PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-assessment of pain by VAS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of stroke/TIA
Endpoint domain: Mortality/survival
Primary endpoint: Procedure/device-related death
Endpoint domain: Mortality/survival